High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay.
Jansen, R W
High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. [electronic resource] - Antimicrobial agents and chemotherapy Mar 1993 - 441-7 p. digital
Publication Type: Journal Article
0066-4804
10.1128/AAC.37.3.441 doi
Antibody Specificity
Antiviral Agents--pharmacology
Base Sequence
Carcinoma, Hepatocellular--pathology
Cell Line
Emtricitabine--analogs & derivatives
Growth Inhibitors--pharmacology
Hepatitis B virus--drug effects
Humans
Liver Neoplasms--pathology
Molecular Sequence Data
Polymerase Chain Reaction--drug effects
Virion--drug effects
Zalcitabine--analogs & derivatives
High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. [electronic resource] - Antimicrobial agents and chemotherapy Mar 1993 - 441-7 p. digital
Publication Type: Journal Article
0066-4804
10.1128/AAC.37.3.441 doi
Antibody Specificity
Antiviral Agents--pharmacology
Base Sequence
Carcinoma, Hepatocellular--pathology
Cell Line
Emtricitabine--analogs & derivatives
Growth Inhibitors--pharmacology
Hepatitis B virus--drug effects
Humans
Liver Neoplasms--pathology
Molecular Sequence Data
Polymerase Chain Reaction--drug effects
Virion--drug effects
Zalcitabine--analogs & derivatives